Get started
Amgen Inc.Amgen Inc.Amgen Inc.

Amgen Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options Bonds

AMGN chart


Full chart

Key facts today

Amgen anticipates Phase 2 trial results for its weight-loss drug MariTide by year-end. Analysts forecast significant weight loss, but concerns over side effects may affect investor interest.
Analyze the impactAnalyze the impact

AMGN upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪154.74 B‬ USD
Dividend yield (indicated)
3.21%
Price to earnings Ratio (TTM)
35.85
Basic EPS (TTM)
7.88 USD
Net income (FY)
‪6.72 B‬ USD
Revenue (FY)
‪28.01 B‬ USD
Shares float
‪536.14 M‬
Beta (1Y)
0.62

Employees


Employees (FY)
‪26.7 K‬
Change (1Y)
‪+1.5 K‬ +5.95%
Revenue / Employee (1Y)
‪1.05 M‬ USD
Net income / Employee (1Y)
‪251.57 K‬ USD

About Amgen Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Robert A. Bradway
Website
amgen.com
Headquarters
Thousand Oaks
Founded
1980
FIGI
BBG000BBS2Y0
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

AMGN news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

AMGN highest yielding bonds


AMGN.GA
Amgen Inc. 8.125% 01-APR-2097
Yield to maturity
6.65%
Maturity date
Apr 1, 2097
US31162BP4
AMGEN 12/43
Yield to maturity
6.02%
Maturity date
May 15, 2043
US31162DU1
AMGEN 23/63
Yield to maturity
5.84%
Maturity date
Mar 2, 2063
AMGN.GV
Amgen Inc. 6.4% 01-FEB-2039
Yield to maturity
5.77%
Maturity date
Feb 1, 2039
US31162DT4
AMGEN 23/53
Yield to maturity
5.74%
Maturity date
Mar 2, 2053
US31162DS6
AMGEN 23/43
Yield to maturity
5.69%
Maturity date
Mar 2, 2043
AMGN.GU
Amgen Inc. 6.9% 01-JUN-2038
Yield to maturity
5.68%
Maturity date
Jun 1, 2038
US31162BH2
AMGEN 2042
Yield to maturity
5.68%
Maturity date
Jun 15, 2042
AMGN.GY
Amgen Inc. 5.75% 15-MAR-2040
Yield to maturity
5.67%
Maturity date
Mar 15, 2040
US31162DK3
AMGEN 22/53
Yield to maturity
5.65%
Maturity date
Mar 1, 2053
US31162BE9
AMGEN 2041
Yield to maturity
5.64%
Maturity date
Oct 1, 2041

Explore more bonds 

Sparks


Curated watchlists where AMGN is featured.

See all sparks 

Frequently Asked Questions


The current price of AMGN is 287.87 USD — it has increased by 0.88% in the past 24 hours. Watch Amgen Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Amgen Inc. stocks are traded under the ticker AMGN.
AMGN stock has fallen by −7.71% compared to the previous week, the month change is a −11.79% fall, over the last year Amgen Inc. has showed a 8.49% increase.
We've gathered analysts' opinions on Amgen Inc. future price: according to them, AMGN price has a max estimate of 405.00 USD and a min estimate of 200.00 USD. Watch AMGN chart and read a more detailed Amgen Inc. stock forecast: see what analysts think of Amgen Inc. and suggest that you do with its stocks.
AMGN reached its all-time high on Jul 25, 2024 with the price of 346.85 USD, and its all-time low was 0.08 USD and was reached on Nov 19, 1984. View more price dynamics on AMGN chart.
See other stocks reaching their highest and lowest prices.
AMGN stock is 3.56% volatile and has beta coefficient of 0.62. Track Amgen Inc. stock price on the chart and check out the list of the most volatile stocks — is Amgen Inc. there?
Today Amgen Inc. has the market capitalization of ‪150.48 B‬, it has decreased by −7.13% over the last week.
Yes, you can track Amgen Inc. financials in yearly and quarterly reports right on TradingView.
Amgen Inc. is going to release the next earnings report on Feb 4, 2025. Keep track of upcoming events with our Earnings Calendar.
AMGN earnings for the last quarter are 5.58 USD per share, whereas the estimation was 5.27 USD resulting in a 5.79% surprise. The estimated earnings for the next quarter are 5.04 USD per share. See more details about Amgen Inc. earnings.
Amgen Inc. revenue for the last quarter amounts to ‪8.50 B‬ USD, despite the estimated figure of ‪8.50 B‬ USD. In the next quarter, revenue is expected to reach ‪8.85 B‬ USD.
AMGN net income for the last quarter is ‪2.83 B‬ USD, while the quarter before that showed ‪746.00 M‬ USD of net income which accounts for 279.36% change. Track more Amgen Inc. financial stats to get the full picture.
Yes, AMGN dividends are paid quarterly. The last dividend per share was 2.25 USD. As of today, Dividend Yield (TTM)% is 3.17%. Tracking Amgen Inc. dividends might help you take more informed decisions.
Amgen Inc. dividend yield was 2.96% in 2023, and payout ratio reached 68.24%. The year before the numbers were 2.95% and 64.07% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 21, 2024, the company has ‪26.70 K‬ employees. See our rating of the largest employees — is Amgen Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Amgen Inc. EBITDA is ‪12.09 B‬ USD, and current EBITDA margin is 44.11%. See more stats in Amgen Inc. financial statements.
Like other stocks, AMGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Amgen Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Amgen Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Amgen Inc. stock shows the buy signal. See more of Amgen Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.